Black tea extract prevents lipopolysaccharide-induced NF-κB signaling and attenuates dextran sulfate sodium-induced experimental colitis

BMC Complementary and Alternative Medicine

Volumn 11, Issue , 2011, Pages

  Song, Young A ^a   Park, Young Lan ^a   Kim, Kyu Yeol ^a   Chung, Cho Yun ^a   Lee, Gi Hoon ^a   Cho, Dae Ho ^a   Ki, Ho Seok ^a   Park, Kang Jin ^a   Cho, Sung Bum ^a   Lee, Wan Sik ^a   Kim, Nacksung ^a   Ahn, Bong Whan ^a   Joo, Young Eun ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Black tea; Colon inflammation; Dextran sulfate sodium; Macrophage; Nf b

Indexed keywords

BLACK TEA EXTRACT; CASPASE 3; DEXTRAN SULFATE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 23P19; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; CYTOKINE; PLANT EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WEIGHT REDUCTION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DISEASE MODEL; DOWN REGULATION; GENETICS; HUMAN; IMMUNOLOGY; TEA;

ANIMALS; CAMELLIA SINENSIS; CELLS, CULTURED; COLITIS; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; NF-KAPPA B; PLANT EXTRACTS; SIGNAL TRANSDUCTION;

EID: 80053651921     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-11-91     Document Type: Article

References (34)

1. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004, 343:1-19.
2. Barnes PM, Adams PF, Powell-Griner E. Health characteristics of the Asian adult population: United States, 2004-2006. Adv Data 2008, 394:1-22.
3. Khan N, Mukhtar H. Tea polyphenols for health promotion. Life Sci 2007, 81:519-533. 10.1016/j.lfs.2007.06.011, 17655876.
4. Khan N, Mukhtar H. Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett 2008, 269:269-280. 10.1016/j.canlet.2008.04.014, 2996277, 18501505.
5. Butt MS, Sultan MT. Green tea: nature's defense against malignancies. Crit Rev Food Sci Nutr 2009, 49:463-473. 10.1080/10408390802145310, 19399671.
6. Chen D, Milacic V, Chen MS, Wan SB, Lam WH, Huo C, Landis-Piwowar KR, Cui QC, Wali A, Chan TH, Dou QP. Tea polyphenols, their biological effects and potential molecular targets. Histol Histopathol 2008, 23:487-496.
7. Sharma V, Rao LJ. A thought on the biological activities of black tea. Crit Rev Food Sci Nutr 2009, 49:379-404. 10.1080/10408390802068066, 19399668.
8. Aneja R, Odoms K, Denenberg AG, Wong HR. Theaflavin, a black tea extract, is a novel anti-inflammatory compound. Crit Care Med 2004, 32:2097-2103. 10.1097/01.CCM.0000142661.73633.15, 15483420.
9. Gosslau A, En Jao DL, Huang MT, Ho CT, Evans D, Rawson NE, Chen KY. Effects of the black tea polyphenol theaflavin-2 on apoptotic and inflammatory pathways in vitro and in vivo. Mol Nutr Food Res 2010, 54:1-11.
10. Cai F, Li C, Wu J, Min Q, Ouyang C, Zheng M, Ma S, Yu W, Lin F. Modulation of the oxidative stress and nuclear factor kappaB activation by theaflavin 3,3'-gallate in the rats exposed to cerebral ischemia-reperfusion. Folia Biol (Praha) 2007, 53:164-172.
11. Huang MT, Liu Y, Ramji D, Lo CY, Ghai G, Dushenkov S, Ho CT. Inhibitory effects of black tea theaflavin derivatives on 12-O-tetradecanoylphorbol-13-acetate-induced inflammation and arachidonic acid metabolism in mouse ears. Mol Nutr Food Res 2006, 50:115-122. 10.1002/mnfr.200500101, 16404705.
12. Zhao J, Jin X, Yaping E, Zheng ZS, Zhang YJ, Athar M, DeLeo VA, Mukhtar H, Bickers DR, Wang ZY. Photoprotective effect of black tea extracts against UVB-induced phototoxicity in skin. Photochem Photobiol 1999, 70:637-644. 10.1111/j.1751-1097.1999.tb08263.x, 10546558.
13. Ukil A, Maity S, Das PK. Protection from experimental colitis by theaflavin-3,3'-digallate correlates with inhibition of IKK and NF-kappaB activation. Br J Pharmacol 2006, 149:121-131. 10.1038/sj.bjp.0706847, 1629406, 16880762.
14. Maity S, Ukil A, Karmakar S, Datta N, Chaudhuri T, Vedasiromoni JR, Ganguly DK, Das PK. Thearubigin, the major polyphenol of black tea, ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis. Eur J Pharmacol 2003, 470:103-112. 10.1016/S0014-2999(03)01760-6, 12787838.
15. Dharmani P, Chadee K. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key. Curr Mol Pharmacol 2008, 1:195-212. 10.2174/1874467210801030195, 20021434.
16. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007, 117:514-521. 10.1172/JCI30587, 1804356, 17332878.
17. Podolsky DK, Xavier RJ. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434. 10.1038/nature06005, 17653185.
18. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008, 134:577-594. 10.1053/j.gastro.2007.11.059, 18242222.
19. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002, 347:417-429. 10.1056/NEJMra020831, 12167685.
20. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007, 117:514-521. 10.1172/JCI30587, 1804356, 17332878.
21. Karrasch T, Jobin C. NF-κB and the intestine: friend or foe?. Inflamm Bowel Dis 2007, 14:114-124.
22. Perkins ND, Gilmore TD. Good cop, bad cop: the different faces of NF-κB. Cell Death Differ 2006, 13:759-772. 10.1038/sj.cdd.4401838, 16410803.
23. Hayden MS, Ghosh S. Signaling to NF-κB. Genes Dev 2004, 18:2195-2224. 10.1101/gad.1228704, 15371334.
24. Lawrence T, Bebien M, Liu GY, Nizet V, Karin M. IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature 2005, 434:1138-1143. 10.1038/nature03491, 15858576.
25. Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT. Experimetnal models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 2005, 206:260-276. 10.1111/j.0105-2896.2005.00291.x, 16048554.
26. Lorenz RG, McCracken VJ, Elson CO. Animal models of intestinal inflammation: ineffective communication between coalition members. Springer Semin Immunopathol 2005, 27:233-247. 10.1007/s00281-005-0208-4, 16028027.
27. Chambers TJ, Owens JM, Hattersley G, Jat PS, Noble MD. Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse. Proc Natl Acad Sci USA 1993, 90:5578-5582. 10.1073/pnas.90.12.5578, 46764, 8390670.
28. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA 1989, 86:2336-2340. 10.1073/pnas.86.7.2336, 286907, 2494664.
29. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993, 69:238-249.
30. Dieleman LA, Palmen MJ, Akol H, Bloemena E, Peña AS, Meuwissen SG, Van Rees EP. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 1998, 114:385-391. 10.1046/j.1365-2249.1998.00728.x, 1905133, 9844047.
31. Williams KL, Fuller CR, Dieleman LA, DaCosta CM, Haldeman KM, Sartor RB, Lund PK. Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone. Gastroenterology 2001, 120:925-937. 10.1053/gast.2001.22470, 11231946.
32. Song YA, Park YL, Yoon SH, Kim KY, Cho SB, Lee WS, Chung IJ, Joo YE. Black tea polyphenol theaflavin suppresses LPS-induced ICAM-1 and VCAM-1 expression via blockage of NF-κB and JNK activation in intestinal epithelial cells. Inflamm Res 2011, 60:493-500. 10.1007/s00011-010-0296-z, 21184129.
33. Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 2005, 9:59-71. 10.1111/j.1582-4934.2005.tb00337.x, 15784165.
34. Schultz DR, Harrington WJ. Apoptosis: programmed cell death at a molecular level. Semin Arthritis Rheum 2003, 32:345-369. 10.1053/sarh.2003.50005, 12833244.